To identify therapeutically relevant drug targets of CC in individuals with diabetes, differentially expressed plasma proteins were divided into four regions according to their functions: glucose tolerance and insulin sensitivity, immunity and inflammation, lipoprotein metabolism and transport, and oxidation and antioxidation. This evidence concerns the gene INS and diabetes mellitus.